Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 640-410-2 | CAS number: 2594-75-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
No data are available to assess the skin sensitisation potential of the target substance Methyl-tris acetonoximo-silane. Thus, available data from the source substance WASOX-MMAC2 was used in a read-across approach. In a dermal sensitisation study conducted according to OECD 429 with "WASOX-MMAC2" suspended in AOO (4:1 v/v acetone/olive oil), young adult female CBA/CaOlaHsd mice (5 per dose group) were tested at concentrations of 25% (v/v), 50% (v/v) and 100% (undiluted) in a local lymph node assay (LLNA). There was no mortality nor clinical observations nor effects on body weights observed. None of the tested concentrations of the test substance reached the stimulation index (SI) threshold of 3. Therefore, no EC3 value could be determined. Application of the positive control substance hexyl cinnamic aldehyde (25%) resulted in a SI of 10.2. This result proves the sensitivity of the strain of animals used and the reliability of the experimental technique.
Based on the results from the source substance, the target substance can be considered as non-sensitising to the skin.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- The source compound WASOX-MMAC2 (A mixture of: propan-2-one-O,O'-(methoxymethylsilandiyl)dioxime; propan-2-one-O-(dimethoxymethylsilyl)oxime; propan-2-one-O,O',O''-(methylsilantriyl)trioxime; EC No. 460-110-3) is considered a suitable read across partner for the target substance MAC (CAS 2594-75-4). This read-across is based on the hypothesis that source and target substances have similar toxicological properties because:
- structural similarity of the target and the source substances (the presence or absence of additional functional groups or substituents that could influence the behaviour of a chemical),
- similarity in physico-chemical profile of the source and target substances (rapid decomposition in water under cleavage of the same substance (acetone oxime)).
Both substances are similar in terms of the substitution pattern at the silicon atom (i.e. acetoneoximo and methyl group(s)). Both substances exhibit consequently similar physico-chemical properties (rapid decomposition in water, decomposition upon heating to determine boiling point). - Reason / purpose for cross-reference:
- read-across source
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50 and 100%
- No. of animals per dose:
- 5
- Details on study design:
- MAIN STUDY
The test substance was administered in 3 concentrations to the dorsal surfaces of the ears of the animals of the test substance groups. In a manner identical to that of animals in the treatment groups animals of one negative control group and one positive control group were treated with AOO and HCA respectively. Each animal was treated for 3 consecutive days. 3 days after the last administration the proliferation of the Iymphocytes of the draining Iymph nodes was measured by the determination of the amounts of incorporated 3HTdR.
Administration of the test substance:
Route of Administration: epicutaneous administration to the dorsal surface of each ear
Administration volume: 25 µL
Incorporation of 3H-methyl thymidine in vivo:
5 days after the first topical administration, each animal received 20 µCi 3HTdR by slow intravenous administration. The injection solution containing nominal 80 µCi/mL 3HTdR was prepared by the dilution of 1.152 mL 3HTdR (amersham pharmacia biotech, Kat. Nr.:TRA 310, batch 315, specific activity 2.0 Ci/mmol, radioactive concentration 1 mCi/mL, radiochemical purity 98.6%, thymine content 0.2%) with 13.248 mL PBS. Several minutes prior to 3HTdR administration the animals were kept restrained in Plexiglas-tubes and the tail veins were visualised by placing the tails in warm water. Then 250 µL of the injection solution were intravenously administered to each animal.
Preparation of single cell suspensions and determination of incorporated 3H-methyl thymidine:
Approximately 5 hours after 3HTdR injection all animals were sacrificed by carbon dioxide asphyxiation and the draining auricular lymph nodes were rapidly excised. The Iymph nodes of each group were pooled in PBS. A single cell suspension (SCS) of Iymphnode cells (LNC) nwas prepared by gentle mechanical disaggregation of the pooled Iymph nodes through a 70 µm cell strainer. The SCSs were then transferred into centrifuge tubes and LNC were pelleted by centrifugation (4 °C, max. 200 g, 10 min). Afterwards supernatants were removed by aspiration. Then the LNC were resuspended and washed twice with PBS. After the final washing the supernatants were removed leaving just a small volume < 0.5 mL) and
macromolecules were precipitated by incubation with 5 % trichloroacetic acid (TCA) at 4 °C overnight. Each precipitate was pelleted by centrifugation (4 °C, max. 200 g, 10min) and resuspended in 1 mL TCA. This suspension was transferred into scintillation vials containing 10 mL scintillation cocktail (Packard Bioscience: Ultima Gold, Bestellnr. 6013329) and 3HTdR incorporation was determined with a ß-scintillation counter.
INVESTIGATIONS
General observations: All animals were observed at least once daily for behavioural changes or signs of toxicity
Body masses: The body mass of each animal was recorded on Days 1 and 6
Skin reactions: The application sites were visually checked for local irritations once a day from Days 1-6. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Calculation of the stimulation indices (Sls):
Results are presented as test/control ratio (Stimulation index), calculated as dpm test group/dpm negative control group.
(dpm = disintegrations per minute, corrected by the subtraction of the background) - Positive control results:
- Application of 25% HCA in AOO resulted in an SI of 10.2. This result proves the sensitivity of the strain of animals used and the reliability of the experimental technique.
- Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- 25%
- Remarks on result:
- other: no indication of sensitisation
- Key result
- Parameter:
- SI
- Value:
- 0.8
- Test group / Remarks:
- 50%
- Remarks on result:
- other: no indication of sensitisation
- Key result
- Parameter:
- SI
- Value:
- 0.7
- Test group / Remarks:
- 100%
- Remarks on result:
- other: no indication of sensitisation
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
: The SIs of the test substance groups were between 0.7 and 1. For detailed results please refer to table 1 in box "Any other information on results incl. tables".
SKIN REACTIONS: No local skin irritations were observed at the application sites of all animals of all test substance groups and both control groups throughout the whole study.
MORTALITY: No mortality occurred
GENERAL OBSERVATIONS: One animal of the high dose group had reduced motoric activities on Day 6. In all other animals no abnormal behaviour or clinical signs were detected during the experiment.
BODY MASS: Body masses and body mass gains of all animals were in the range to be expected from animals of the same strain, sex and age. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance "WASOX-MMAC2" is not sensitizing under the conditions of this LLNA study (OECD 429).
- Executive summary:
In a dermal sensitization study conducted according to OECD 429 with "WASOX-MMAC2" suspended in AOO (4:1 v/v acetone/olive oil), young adult female CBA/CaOlaHsd mice (5 per dose group) were tested at concentrations of 25% (v/v), 50% (v/v) and 100% (undiluted) in a local lymph node assay (LLNA). There was no mortality nor clinical observations nor effects on body weights observed. None of the tested concentrations of the test substance reached the stimulation index (SI) threshold of 3. Therefore, no EC3 value could be determined. Application of the positive control substance hexyl cinnamic aldehyde (25%) resulted in a SI of 10.2. This result proves the sensitivity of the strain of animals used and the reliability of the experimental technique. In this study, the test substance is not a dermal sensitizer.
This information is used in a read-across approach in the assessment of the target substance.
Reference
Table 1: DPM results and calculated SIs
Test group |
DPM |
SI |
Negative control |
4197 |
1 |
Low dose |
4217 |
1.0 |
Mid dose |
3536 |
0.8 |
High dose |
2919 |
0.7 |
Positive control |
42767 |
10.2 |
Rationale for selection of the concentrations:
In a range finding study the test substance as it is (100%) was administered to two animals. In this study the animals were treated in the same manner as in a main study with 25 µL test substance on the dorsum of each ear on three consecutive days. None of the animals showed overt systemic toxicity, excessive local skin irritation or an increase in ear thickness in the range finding study. Therefore, 100% was chosen as highest test substance concentration and ear thickness measurement was not performed in the main study.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
No data are available to assess the skin sensitisation potential of the target substance Methyl-tris acetonoximo-silane. Thus, available data from the source substance WASOX-MMAC2 was used in a read-across approach. In a dermal sensitisation study conducted according to OECD 429 with "WASOX-MMAC2" suspended in AOO (4:1 v/v acetone/olive oil), young adult female CBA/CaOlaHsd mice (5 per dose group) were tested at concentrations of 25% (v/v), 50% (v/v) and 100% (undiluted) in a local lymph node assay (LLNA). There was no mortality nor clinical observations nor effects on body weights observed. None of the tested concentrations of the test substance reached the stimulation index (SI) threshold of 3. Therefore, no EC3 value could be determined. Application of the positive control substance hexyl cinnamic aldehyde (25%) resulted in a SI of 10.2. This result proves the sensitivity of the strain of animals used and the reliability of the experimental technique.
Based on the results from the source substance, the target substance can be considered as non-sensitising to the skin.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In a dermal sensitisation study according to OECD 429, female mice were tested negative for the source substance WASOX-MMAC2. Based on the results from the read-across partner, no classification of the target substance Methyl-tris acetonoximo-silane is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.